Key Record Dates
ClinicalTrials.gov Identifier: | NCT04702880 |
---|---|
Brief Title: | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer |
First Submitted : | January 7, 2021 |
First Submitted that Met QC Criteria : | January 7, 2021 |
First Posted : | January 11, 2021 |
Last Update Submitted that Met QC Criteria : | January 17, 2023 |
Last Update Posted : | January 18, 2023 |